Sufentanil, also known as R30730 or brand name Sufenta, is a synthetic opioid analgesic drug which is considerably more potent than its parent drug, fentanyl, morphine. It is used for producing anesthesia for surgery. It may also be used with other medicines as part of epidural anesthesia during labor and delivery to decrease pain. Globally, development of efficient and advanced technology and increase in number of medical surgeries and gynaecological surgeries are the prime growth drivers of Sufentanil Citrate market. Apart from this, augmentation in cardiovascular diseases and associated surgeries, and emerging economies are expected to be the key growth drivers during the period of study.
Geographically North America dominates the
sufentanil citrate market driven by best in class infrastructure, easy access to healthcare, higher awareness amongst physicians about the advanced technological treatment, higher spending on R&D by large pharmaceutical players in the region and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for sufentanil citrate market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China and India in this region.
This report identifies the global Sufentanil Citrate market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Sufentanil Citrate market.
This report segments Sufentanil Citrate market on the basis of type, procedures, and regional market as follows:
- This report on Sufentanil Citrate Market is segmented on the basis of major applications of sulfentanil citrate. Some of the major applications of sulfantanil citrate covered in this report as follows: Surgery, Epidural Anaesthesia and Medicinal Application and for nutraceuticals
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the Sufentanil Citrate market. Some of the major companies’ profiles in detail are as follows:
- Wuhan Fengzhulin
- Macfarlan Smith
- Mallinckrodt Pharmaceuticals
- Akorn, Inc